Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Journal of Biomedical Science | journal | 2.606 Q1 | 110 | 96 | 288 | 10080 | 2990 | 288 | 8.54 | 105.00 | 40.92 | |
2 | Drugs | journal | 2.352 Q1 | 188 | 138 | 490 | 9241 | 4984 | 465 | 10.27 | 66.96 | 38.00 | |
3 | npj Breast Cancer | journal | 2.275 Q1 | 46 | 95 | 346 | 4112 | 2003 | 339 | 5.65 | 43.28 | 54.50 | |
4 | npj Vaccines | journal | 2.127 Q1 | 47 | 182 | 421 | 9795 | 2689 | 404 | 6.60 | 53.82 | 45.87 | |
5 | International Journal of Neuropsychopharmacology | journal | 1.525 Q1 | 125 | 79 | 261 | 4188 | 1265 | 254 | 4.59 | 53.01 | 45.25 | |
6 | Molecular Therapy - Oncolytics | journal | 1.494 Q1 | 42 | 97 | 488 | 5554 | 2595 | 478 | 5.35 | 57.26 | 43.28 | |
7 | CNS Neuroscience and Therapeutics | journal | 1.473 Q1 | 91 | 418 | 491 | 24328 | 2516 | 434 | 4.95 | 58.20 | 43.37 | |
8 | Journal of Psychiatry and Neuroscience | journal | 1.317 Q1 | 114 | 55 | 178 | 3072 | 615 | 142 | 3.13 | 55.85 | 49.38 | |
9 | Biologics: Targets and Therapy | journal | 1.276 Q1 | 47 | 17 | 70 | 681 | 364 | 70 | 5.81 | 40.06 | 49.44 | |
10 | Antimicrobial Resistance and Infection Control | journal | 1.256 Q1 | 66 | 143 | 522 | 6549 | 2764 | 509 | 4.86 | 45.80 | 52.97 | |
11 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.220 Q1 | 47 | 43 | 142 | 2437 | 622 | 142 | 4.21 | 56.67 | 43.39 | |
12 | Vaccines | journal | 1.201 Q1 | 85 | 1854 | 4462 | 105389 | 22996 | 4375 | 5.37 | 56.84 | 46.93 | |
13 | Orphanet Journal of Rare Diseases | journal | 1.182 Q1 | 136 | 386 | 1277 | 16047 | 4683 | 1226 | 3.33 | 41.57 | 55.03 | |
14 | Therapeutic Advances in Psychopharmacology | journal | 1.179 Q1 | 43 | 34 | 148 | 2335 | 624 | 142 | 3.45 | 68.68 | 40.96 | |
15 | Therapeutic Advances in Respiratory Disease | journal | 1.179 Q1 | 50 | 78 | 206 | 3651 | 791 | 194 | 3.55 | 46.81 | 40.73 | |
16 | Frontiers in Pharmacology | journal | 1.066 Q1 | 154 | 3463 | 11918 | 215854 | 56071 | 11495 | 4.32 | 62.33 | 45.82 | |
17 | Therapeutic Advances in Drug Safety | journal | 1.035 Q1 | 46 | 27 | 103 | 1296 | 396 | 91 | 3.07 | 48.00 | 47.88 | |
18 | Therapeutic Advances in Infectious Disease | journal | 1.015 Q1 | 29 | 80 | 192 | 3145 | 620 | 163 | 3.25 | 39.31 | 49.09 | |
19 | CPT: Pharmacometrics and Systems Pharmacology | journal | 0.975 Q1 | 55 | 181 | 347 | 6421 | 1102 | 320 | 3.07 | 35.48 | 40.77 | |
20 | Antibiotics | journal | 0.920 Q1 | 77 | 1729 | 4319 | 112476 | 20751 | 4258 | 4.45 | 65.05 | 49.00 | |
21 | AIDS Research and Therapy | journal | 0.872 Q2 | 49 | 89 | 234 | 3234 | 555 | 234 | 2.18 | 36.34 | 48.99 | |
22 | Cancer Chemotherapy and Pharmacology | journal | 0.869 Q2 | 122 | 109 | 496 | 3935 | 1395 | 488 | 2.73 | 36.10 | 37.56 | |
23 | EJNMMI Radiopharmacy and Chemistry | journal | 0.869 Q2 | 28 | 42 | 99 | 1553 | 398 | 95 | 3.59 | 36.98 | 37.30 | |
24 | OpenNano | journal | 0.824 Q2 | 21 | 80 | 73 | 7983 | 473 | 73 | 6.48 | 99.79 | 37.53 | |
25 | World Journal of Men?s Health | journal | 0.824 Q2 | 29 | 72 | 199 | 4234 | 786 | 188 | 3.46 | 58.81 | 21.66 | |
26 | Medicine in Drug Discovery | journal | 0.815 Q2 | 16 | 20 | 68 | 1878 | 328 | 65 | 4.83 | 93.90 | 45.00 | |
27 | Trials | journal | 0.812 Q2 | 98 | 802 | 2956 | 30481 | 6129 | 2785 | 1.93 | 38.01 | 46.45 | |
28 | OncoTargets and Therapy | journal | 0.810 Q2 | 86 | 77 | 1693 | 4228 | 5625 | 1685 | 2.67 | 54.91 | 47.49 | |
29 | Clinical Psychopharmacology and Neuroscience | journal | 0.802 Q2 | 42 | 66 | 242 | 3193 | 652 | 237 | 2.33 | 48.38 | 38.77 | |
30 | Journal of Experimental Pharmacology | journal | 0.778 Q2 | 23 | 41 | 153 | 1868 | 578 | 152 | 3.76 | 45.56 | 30.72 | |
31 | Cardiovascular Therapeutics | journal | 0.769 Q2 | 54 | 34 | 165 | 1509 | 544 | 165 | 3.43 | 44.38 | 38.42 | |
32 | Therapeutics and Clinical Risk Management | journal | 0.752 Q2 | 70 | 90 | 357 | 4189 | 986 | 352 | 2.35 | 46.54 | 38.52 | |
33 | Infection and Drug Resistance | journal | 0.743 Q2 | 65 | 698 | 1733 | 27973 | 5784 | 1701 | 2.87 | 40.08 | 44.32 | |
34 | Medical Cannabis and Cannabinoids | journal | 0.731 Q2 | 13 | 19 | 41 | 621 | 168 | 34 | 3.65 | 32.68 | 39.53 | |
35 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 0.726 Q2 | 13 | 18 | 47 | 751 | 163 | 41 | 3.74 | 41.72 | 36.17 | |
36 | BMC pharmacology & toxicology | journal | 0.710 Q2 | 43 | 77 | 253 | 2925 | 763 | 253 | 2.92 | 37.99 | 43.47 | |
37 | Infection and Chemotherapy | journal | 0.698 Q2 | 38 | 61 | 255 | 1592 | 622 | 217 | 2.07 | 26.10 | 46.29 | |
38 | PPAR Research | journal | 0.698 Q2 | 59 | 15 | 69 | 877 | 199 | 69 | 3.25 | 58.47 | 38.10 | |
39 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.696 Q2 | 57 | 27 | 169 | 1330 | 433 | 166 | 2.60 | 49.26 | 34.83 | |
40 | Clinical Pharmacology: Advances and Applications | journal | 0.695 Q2 | 34 | 11 | 64 | 701 | 156 | 59 | 3.17 | 63.73 | 34.00 | |
41 | Journal of Cannabis Research | journal | 0.692 Q2 | 17 | 39 | 148 | 1666 | 627 | 144 | 4.35 | 42.72 | 47.62 | |
42 | Australian Prescriber | journal | 0.675 Q2 | 40 | 27 | 205 | 415 | 260 | 103 | 1.16 | 15.37 | 54.17 | |
43 | Drug Metabolism and Pharmacokinetics | journal | 0.674 Q2 | 75 | 38 | 182 | 1462 | 454 | 179 | 2.94 | 38.47 | 27.18 | |
44 | Neuropsychopharmacology Reports | journal | 0.660 Q2 | 22 | 105 | 201 | 3867 | 480 | 199 | 2.40 | 36.83 | 28.02 | |
45 | PharmacoEconomics - Open | journal | 0.658 Q2 | 20 | 74 | 207 | 3193 | 381 | 197 | 1.94 | 43.15 | 43.63 | |
46 | Vascular Health and Risk Management | journal | 0.647 Q2 | 82 | 86 | 224 | 3733 | 606 | 219 | 2.70 | 43.41 | 39.10 | |
47 | Journal of Cardiovascular Development and Disease | journal | 0.621 Q2 | 32 | 497 | 709 | 27150 | 1727 | 700 | 2.40 | 54.63 | 33.67 | |
48 | Frontiers in Medical Technology | journal | 0.602 Q2 | 15 | 67 | 210 | 2797 | 661 | 193 | 2.60 | 41.75 | 34.72 | |
49 | European Review for Medical and Pharmacological Sciences | journal | 0.580 Q2 | 88 | 1330 | 3737 | 39590 | 8926 | 3572 | 2.16 | 29.77 | 39.35 | |
50 | Drugs - Real World Outcomes | journal | 0.564 Q2 | 21 | 63 | 152 | 2205 | 336 | 150 | 2.16 | 35.00 | 46.28 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®